Young, low-income women face breast cancer treatment delays, with research showing they're more likely to experience delays at multiple stages of care.
An NR supplement failed to slow Parkinson's disease progression in a major Phase III trial, according to JAMA research.
The enzyme FAH may predict resistance to CDK4/6 inhibitors in hormone receptor-positive breast cancer, offering potential for better treatment strategies.
A Danish study reveals type 2 diabetes patients face over twice the cancer risk, with the disparity growing significantly in recent years,…
New research into tumor blood vessels may predict colorectal cancer survival outcomes, analyzing 837 patients to identify prognostic blood vessel patterns.
A new CRISPR tool identifies genes behind lymphoma drug resistance, offering new therapeutic targets for fighting cancer progression.
Tumors can hide p53 mutations from T cells, posing challenges for personalized immunotherapy. Researchers find tumors conceal p53 neoantigens, making detection
Chemotherapy causes lasting damage in healthy tissues, leading to DNA damage in children.